Harvey L. Kellman
Keine laufenden Positionen mehr
Profil
Harvey L.
Kellman served as a Director for Correvio Pharma Corp.
and EACOM Timber Corp.
from 2000 to 2004.
He was also a Founding Director for BioMimetic Therapeutics, Inc. in 2004 and a Director for Intellect Neurosciences, Inc. from 2006 to 2010.
Kellman holds a graduate degree from the Illinois Institute of Technology, an MBA from Northwestern University, and an undergraduate degree from Purdue University.
Ehemalige bekannte Positionen von Harvey L. Kellman
Unternehmen | Position | Ende |
---|---|---|
INTELLECT NEUROSCIENCES, INC. | Direktor/Vorstandsmitglied | 24.01.2010 |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 01.04.2004 |
CORREVIO PHARMA CORP. | Direktor/Vorstandsmitglied | 01.01.2004 |
BioMimetic Therapeutics, Inc.
BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Direktor/Vorstandsmitglied | 01.01.2004 |
Ausbildung von Harvey L. Kellman
Purdue University | Undergraduate Degree |
Northwestern University | Masters Business Admin |
Illinois Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Intellect Neurosciences, Inc.
Intellect Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Intellect Neurosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of disease-modifying therapeutic agents. It specializes in treatment and prevention of neurodegenerative conditions, collectively known as proteinopathies, which include alzheimer's, parkinson's and huntington disease. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
BioMimetic Therapeutics, Inc.
BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Health Technology |
Correvio Pharma Corp.
Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Non-Energy Minerals |